Loading...

Home
ETF
ADPT

ADPT

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ADPT News

Julie Rubinstein Sells 57,180 Shares of Adaptive Biotechnologies

Adaptive Biotechnologies Executive Stock Sale

2d agoNASDAQ.COM

Adaptive Biotechnologies Executive Sells Shares

Adaptive Biotechnologies Executive Sells Shares Amid Strong Revenue Growth

Apr 08 2026Fool

Adaptive Biotechnologies Executive Sells Shares

Apr 08 2026NASDAQ.COM

Adaptive Biotechnologies Executive Sells Shares Worth $1.21 Million

Mar 31 2026Fool

Adaptive Biotechnologies Executive Sells Shares

Mar 31 2026NASDAQ.COM

Adaptive Biotechnologies Executive Sells 179,703 Shares

Mar 26 2026Fool

Adaptive Biotechnologies Executive Sells 179,703 Shares for $2.37 Million

Mar 26 2026NASDAQ.COM

Analysis of Insider Stock Transactions at Adaptive Biotechnologies

Mar 26 2026Fool

Adaptive Biotechnologies Officer Plans to Sell $4.66 Million in Common Stock via Form 144

Mar 02 2026moomoo

Adaptive Biotechnologies Stock Rating Upgraded

Feb 21 2026Yahoo Finance

Adaptive Biotechnologies Reports Strong Q4 2025 Earnings Growth and Positive Outlook

Feb 06 2026seekingalpha

Adaptive Biotechnologies to Announce Q4 Earnings on February 5th

Feb 04 2026seekingalpha

Adaptive Biotechnologies Reports 55% Revenue Growth to $277 Million for FY 2025

Jan 13 2026Benzinga

Planet Labs PBC Secures Nine-Figure Deal with Swedish Armed Forces, Shares Surge 7%

Jan 12 2026Benzinga